Adaptive Biotechnologies Corp
No standout activity across the feeds we track.
Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers…
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-11-13 | RUBINSTEIN JULIE | Insider | SELL | 11,466 | $28.93 | $331,711 |
| 2026-11-12 | RUBINSTEIN JULIE | Insider | SELL | 11,881 | $29.40 | $349,301 |
| 2026-11-11 | BOBULSKY SUSAN | Insider | SELL | 1,875 | $32.00 | $60,000 |
| 2026-11-11 | RUBINSTEIN JULIE | Insider | SELL | 6,898 | $31.22 | $215,356 |
| 2026-11-11 | RUBINSTEIN JULIE | Insider | SELL | 4,983 | $30.29 | $150,935 |
| 2026-11-10 | RUBINSTEIN JULIE | Insider | SELL | 1,900 | $30.41 | $57,779 |
| 2026-11-10 | RUBINSTEIN JULIE | Insider | SELL | 9,981 | $29.35 | $292,942 |
| 2026-11-09 | RUBINSTEIN JULIE | Insider | SELL | 2,400 | $30.58 | $73,392 |
| 2026-11-09 | RUBINSTEIN JULIE | Insider | SELL | 8,381 | $30.15 | $252,687 |
| 2026-11-09 | RUBINSTEIN JULIE | Insider | SELL | 1,100 | $28.87 | $31,757 |
| 2026-11-06 | RUBINSTEIN JULIE | Insider | SELL | 3,481 | $27.88 | $97,050 |
| 2026-11-06 | RUBINSTEIN JULIE | Insider | SELL | 8,400 | $27.32 | $229,488 |
| 2026-11-05 | RUBINSTEIN JULIE | Insider | SELL | 500 | $27.70 | $13,850 |
| 2026-11-05 | RUBINSTEIN JULIE | Insider | SELL | 5,455 | $26.88 | $146,630 |
| 2026-11-05 | RUBINSTEIN JULIE | Insider | SELL | 5,926 | $26.10 | $154,669 |
| 2026-11-04 | RUBINSTEIN JULIE | Insider | SELL | 7,881 | $26.60 | $209,635 |
| 2026-11-04 | RUBINSTEIN JULIE | Insider | SELL | 4,000 | $25.78 | $103,120 |
| 2026-11-03 | RUBINSTEIN JULIE | Insider | SELL | 11,881 | $25.98 | $308,668 |
| 2026-11-02 | RUBINSTEIN JULIE | Insider | SELL | 2,585 | $26.34 | $68,089 |
| 2026-11-02 | RUBINSTEIN JULIE | Insider | SELL | 9,296 | $25.23 | $234,538 |